Cubist Systematic Strategies’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$416K Buy
+5,600
New +$567K ﹤0.01% 2363
2025
Q1
Sell
-10,000
Closed -$1.85M 3153
2024
Q4
$1.85M Sell
10,000
-1,300
-12% -$252K 0.01% 1408
2024
Q3
$2.38M Buy
11,300
+2,000
+22% +$347K 0.01% 1326
2024
Q2
$1.24M Sell
9,300
-1,600
-15% -$303K 0.01% 1617
2024
Q1
$2.34M Sell
10,900
-10,600
-49% -$2.08M 0.01% 1521
2023
Q4
$4.37M Buy
21,500
+7,800
+57% +$1.26M 0.03% 953
2023
Q3
$2.72M Buy
+13,700
New +$3.46M 0.02% 1149

Other funds holding INSP

Cubist Systematic Strategies's INSP Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Inspire Medical Systems (INSP) in Q3 2025: 97,387 shares worth $7.23M. The stake represents 0.03% of the portfolio and ranks #744 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in INSP as recently as Q2 2024.

Cubist Systematic Strategies first reported a position in INSP in Q1 2019 and has held it in 21 quarters since. The position peaked at $30M in Q1 2023. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • Cubist Systematic Strategies held 97,387 shares of Inspire Medical Systems worth $7.23M as of Q3 2025.
  • Inspire Medical Systems was a new Cubist Systematic Strategies position in Q3 2025.
  • Inspire Medical Systems made up 0.03% of Cubist Systematic Strategies's portfolio in Q3 2025, its #744 holding.
  • Cubist Systematic Strategies first reported a position in Inspire Medical Systems in Q1 2019 and has held it in 21 quarters since.
  • Cubist Systematic Strategies's Inspire Medical Systems position peaked at $30M in Q1 2023.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.